4-hydroxyclomiphene has been researched along with calcitriol in 1 studies
| Studies (4-hydroxyclomiphene) | Trials (4-hydroxyclomiphene) | Recent Studies (post-2010) (4-hydroxyclomiphene) | Studies (calcitriol) | Trials (calcitriol) | Recent Studies (post-2010) (calcitriol) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 16,107 | 1,224 | 3,710 |
| Protein | Taxonomy | 4-hydroxyclomiphene (IC50) | calcitriol (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0093 | |
| Vitamin D3 receptor | Homo sapiens (human) | 0.3401 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.0093 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koga, M; Sutherland, RL | 1 |
1 other study(ies) available for 4-hydroxyclomiphene and calcitriol
| Article | Year |
|---|---|
Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation.
Topics: Breast Neoplasms; Calcitriol; Cell Division; Cell Line; Clomiphene; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Humans; Kinetics; Pyrrolidines; Receptors, Calcitriol; Receptors, Estradiol; Receptors, Steroid; Tamoxifen; Thiophenes; Tretinoin | 1991 |